Tan, Tao
Rodriguez-Ruiz, Alejandro
Zhang, Tianyu
Xu, Lin
Beets-Tan, Regina G. H.
Shen, Yingzhao
Karssemeijer, Nico
Xu, Jun
Mann, Ritse M.
Bao, Lingyun https://orcid.org/0000-0003-0367-6690
Article History
Received: 8 July 2022
Accepted: 9 December 2022
First Online: 16 January 2023
Declarations
:
: The use of patient electronic health records in this study was approved by Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine. Written informed consent was obtained from all patients.
: Not applicable.
: Tao Tan, Employee, Netherlands Cancer Institute, and Faculty of Applied Science, Macao Polytechnic University. Alejandro Rodriguez-Ruiz, Former Employee, ScreenPoint Medical BV. Tianyu Zhang, Employee, Netherlands Cancer Institute, and GROW School for Oncology and Development Biology, Maastricht University. Lin Xu, Employee, School of Information Science and Technology, ShanghaiTech University. Regina G. H. Beets-Tan, Group leader, Netherlands Cancer Institute, and GROW School for Oncology and Development Biology, Maastricht University. Member of the Insights into Imaging Advisory Editorial Board. She has not taken part in the review or selection process of this article. Yingzhao Shen, Employee, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine. Nico Karssemeijer, Founder and shareholder of ScreenPoint Medical BV, QView Medical Inc., and Volpara Healthcare Ltd. Jun Xu, Employee, Nanjing University of Information Science and Technology. Ritse M. Mann, Scientific advisor, ScreenPoint Medical; Research agreement, Siemens Healthcare. Member of the Insights into Imaging Advisory Editorial Board. He has not taken part in the review or selection process of this article. Lingyun Bao, Employee, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine.